Wound Care Business Navigator: Documentation For The New LCD

The updated Medicare Local Coverage Determination (LCD) policy on Skin Substitute Grafts and Cellular and Tissue-Based Products (CTPs) introduces significant changes for wound care professionals treating diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). This lecture will provide an in-depth overview of the revised policy, focusing on the expanded indications for use over exposed muscle, tendon, and bone, extended therapy duration from 12 to 16 weeks, and the increased application limit from 4 to 8 per episode of care. The session will highlight key documentation requirements, ICD-10 code updates, and the proper use of the KX modifier to attest to medical necessity for additional applications. Practical strategies for integrating these changes into clinical workflows, ensuring compliance, and optimizing patient outcomes will be discussed. Attendees will gain actionable insights into policy implementation, supported by real-world evidence and case studies. This session will empower wound care professionals to navigate the new policy and enhance patient care outcomes.